SCHEMBL2730918

SCHEMBL2730918

CCOC(=O)c1c(Cl)c2ccccc2n1-c1ccc(C(N)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ RECQL P46063 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ ELANE P08246 5/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ BLM P54132 1/20 0.43
▸ MPI P34949 1/20 0.42
▸ EP300 Q09472 1/20 0.42
▸ PHOSPHO1 Q8TCT1 1/20 0.42
▸ KAT2A Q92830 1/20 0.42
▸ KAT2B Q92831 1/20 0.42
▸ MAPK8 P45983 1/20 0.42
▸ F2RL3 Q96RI0 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730661 0.87 GAA (0.47) GAAALDH1A1MAPTRECQLHPGD
SCHEMBL2730721 0.85 RECQL (0.49) GAAALDH1A1MAPTRECQLHPGD
SCHEMBL2455488 0.82 ELANE (0.53) GAAALDH1A1MAPTELANESMN1; SMN2
SCHEMBL2730920 0.82 GAA (0.44) GAAALDH1A1MAPTRECQLHPGD
SCHEMBL12279719 0.81 HPGD (0.65) GAAALDH1A1MAPTRECQLHPGD
SCHEMBL4639761 0.77 L3MBTL1 (0.55) ALDH1A1MAPTRECQLHPGDHTT
SCHEMBL2887731 0.76 MAPT (0.64) GAAALDH1A1MAPTRECQLHPGD
SCHEMBL17199972 0.75 MAPK8 (0.46) ALDH1A1HPGDMAPK8HDAC6
Hydrochloric Acid SCHEMBL2732706 0.74 MAPK8 (0.45) ALDH1A1HPGDMAPK8HDAC6
SCHEMBL2730314 0.74 CCR2 (0.41) MAPK8RORCHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635567-B1 INDOLE DERIVATIVES RICHTER GEDEON NYRT (HU) 2015-10-28 — — EP disclosed
EP-2635567-A1 INDOLE DERIVATIVES Richter Gedeon Nyrt. (HU) 2013-09-11 — — EP disclosed
US-20130217702-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. 2013-08-22 — — US disclosed
WO-2012059776-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217702-A1 INDOLE DERIVATIVES BDKRB1, BDKRB2, ARRB1 GAA 4787/4885ALDH1A1 1752/4885MAPT 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback